Rituximab’s Second Act: Rethinking B-Cell Depletion for Lupus Treatment
A new review maps where the off-label anti-CD20 antibody rituximab fits in the treatment of systemic lupus erythematosus, from refractory ...
Tag: obinutuzumab
Therapeutic B-cell depletion with obinutuzumab modulates key immunopathological pathways in lupus nephritis: an exploratory whole blood transcriptomic analysis of the phase II NOBILITY trial
In one of the most detailed molecular portraits yet of how a next-generation antibody rewrites the immune system in lupus, ...
Scientists Turn Complement Footprints Into a Second Strike Against Drug-Resistant Cancer Cells
Researchers engineered an anti-C4d antibody that targets complement fragments left on tumor cells that survived antibody therapy, boosting complement-mediated killing ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!